Japan National Institute of Infectious Diseases
Monoclonal antibodies developed for SARS management and vaccines
Published in Law and Health Weekly, June 10th, 2006
According to a recent review from Japan, "SARS-CoV is a new type of human coronavirus identified as a causative agent of severe acute respiratory syndrome (SARS).
"On the occasion of the SARS outbreak, various monoclonal antibodies (mAbs) against SARS-CoV have been developed and applied for diagnosis, clinical management and basic research."
"In this review," Y. Tsunetsugu-Yokota and colleagues at the Japan National Institute of Infectious Diseases in Tokyo wrote, "we overview the biochemical and functional properties and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Bain & Company
New Bain & Company survey shows China looms large as India's pharma competition - Biosyntrx, Inc.
Biosyntrx's dry eye formulation awarded U.S. patent - British Columbia Cancer Agency
Researchers' work from British Columbia Cancer Agency adds to body of knowledge - Business Update
Hi-Ethics to transfer assets to Center for Information Therapy - Centre Hospitalier de l'Universite de Clermont Ferrand
Analgesic action of acetaminophen might involve serotonergic system - Constella Group
Constella Group convenes advisory board led by Tommy G. Thompson - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
